Company Filing History:
Years Active: 2008
Title: Innovations by Qingchuang Chen in Cardiovascular Treatment
Introduction
Qingchuang Chen is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular and cerebrovascular diseases. His innovative approach combines traditional Chinese medicine with modern pharmaceutical practices.
Latest Patents
Qingchuang Chen holds 1 patent for a pharmaceutical composition aimed at treating cardiovascular and cerebrovascular diseases. This composition includes extracts from Radix Salviae Miltiorrhizae, Radix Notoginseng, Radix Astragali, and Bomeol or oil of Lignum Dalbergiae Odoriferae. The formulation is designed to be effective against cerebral ischemia and myocardial ischemia, demonstrating superior effects compared to individual components or their combinations. This invention offers a more effective and convenient solution for various preparations in traditional Chinese medicine.
Career Highlights
Qingchuang Chen is associated with Tianjin Tasly Pharmaceutical Co., Ltd., where he continues to develop innovative pharmaceutical solutions. His work emphasizes the integration of traditional remedies with modern scientific methods, enhancing the efficacy of treatments available for cardiovascular conditions.
Collaborations
Qingchuang Chen collaborates with notable colleagues such as Feng Wei and Dekun Li. Their combined expertise contributes to the advancement of pharmaceutical research and development within their organization.
Conclusion
Qingchuang Chen's contributions to the field of pharmaceuticals, particularly through his innovative patent, highlight the potential of combining traditional medicine with modern science. His work continues to pave the way for more effective treatments for cardiovascular diseases.